Glutathione-mediated effects of lithium in decreasing protein oxidation induced by mitochondrial complex I dysfunction

Journal of Neural Transmission

Volumn 122, Issue 6, 2015, Pages 741-746

  Nascimento, Camila ^a   Kim, Helena Kyunghee ^b   Young, L Trevor ^a,b,c   Mendonça, Karina Martinez ^e   Grinberg, Lea Tenenholz ^a,d   Lafer, Beny ^a   Andreazza, Ana Cristina ^b,c  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b UNIVERSITY OF TORONTO   (Canada)

^c CENTRE FOR ADDICTION AND MENTAL HEALTH   (Canada)

^d UNIVERSITY OF CALIFORNIA   (United States)

^e FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

3 Nitrotyrosine; Carbonylation; Lithium; Mitochondrial complex I; Rotenone

Indexed keywords

GLUTATHIONE; LITHIUM; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE DEHYDROGENASE (UBIQUINONE); ROTENONE; 3-NITROTYROSINE; LITHIUM DERIVATIVE; TYROSINE; UNCOUPLING PROTEIN;

ARTICLE; CELL VIABILITY; CONFOCAL LASER MICROSCOPY; HUMAN; HUMAN CELL; IMMUNOCYTOCHEMISTRY; NEUROBLASTOMA CELL; NEUROBLASTOMA CELL LINE; NITRATION; OXIDATION; PRIORITY JOURNAL; PROTEIN CARBONYLATION; PROTEIN FUNCTION; PROTEIN METABOLISM; PROTEIN OXIDATION; ANALOGS AND DERIVATIVES; ANTAGONISTS AND INHIBITORS; CELL SURVIVAL; DRUG EFFECTS; IMMUNOHISTOCHEMISTRY; METABOLISM; NEUROBLASTOMA; PHYSIOLOGY; TUMOR CELL LINE;

CELL LINE, TUMOR; CELL SURVIVAL; ELECTRON TRANSPORT COMPLEX I; GLUTATHIONE; HUMANS; IMMUNOHISTOCHEMISTRY; LITHIUM COMPOUNDS; NEUROBLASTOMA; PROTEIN CARBONYLATION; ROTENONE; TYROSINE; UNCOUPLING AGENTS;

EID: 84930205149     PISSN: 03009564     EISSN: 14351463     Source Type: Journal    
DOI: 10.1007/s00702-014-1318-8     Document Type: Article

References (28)

1. Allagui MS, Nciri R, Rouhaud MF, Murat JC, El Feki A, Croute F, Vincent C (2009) Long-term exposure to low lithium concentrations stimulates proliferation, modifies stress protein expression pattern and enhances resistance to oxidative stress in SH-SY5Y cells. Neurochem Res 34(3):453–462. doi:10.1007/s11064-008-9804-8
2. Andreazza AC, Shao L, Wang JF, Young LT (2010) Mitochondrial complex I activity and oxidative damage to mitochondrial proteins in the prefrontal cortex of patients with bipolar disorder. Arch Gen Psychiatry 67(4):360–368
3. Bachmann RF, Wang Y, Yuan P, Zhou R, Li X, Alesci S, Du J, Manji HK (2009) Common effects of lithium and valproate on mitochondrial functions: protection against methamphetamine-induced mitochondrial damage. Int J Neuropsychopharmacol 12(6):805–822. doi:10.1017/S1461145708009802
4. Clay HB, Sillivan S, Konradi C (2010) Mitochondrial dysfunction and pathology in bipolar disorder and schizophrenia. Int J Dev Neurosci 29(3):311–324
5. Cui J, Shao L, Young LT, Wang JF (2007) Role of glutathione in neuroprotective effects of mood stabilizing drugs lithium and valproate. Neuroscience 144(4):1447–1453. doi:10.1016/j.neuroscience.2006.11.010
6. Dringen R (2000) Glutathione metabolism and oxidative stress in neurodegeneration. Eur J Biochem 267(16):4903
7. Gawryluk JW, Wang JF, Andreazza AC, Shao L, Young LT (2011) Decreased levels of glutathione, the major brain antioxidant, in post-mortem prefrontal cortex from patients with psychiatric disorders. Int J Neuropsychopharmacol 14(1):123–130
8. Goodwin GM, Malhi GS (2007) What is a mood stabilizer? Psychol Med 37(5):609–614. doi:10.1017/S0033291706009305
9. Halliwell B (2001) Role of free radicals in the neurodegenerative diseases: therapeutic implications for antioxidant treatment. Drugs Aging 18(9):685–716
10. Huzayyin AA, Andreazza AC, Turecki G, Cruceanu C, Rouleau GA, Alda M, Young LT (2014) Decreased global methylation in patients with bipolar disorder who respond to lithium. Int J Neuropsychopharmacol 17(4):561–569. doi:10.1017/S1461145713001569
11. Jeong SY, Seol DW (2008) The role of mitochondria in apoptosis. BMB Rep 41(1):11–22
12. Kamat JP (2006) Peroxynitrite: a potent oxidizing and nitrating agent. Indian J Exp Biol 44(6):436–447
13. Karimollah AR, Ghasemi M, Ghahremani MH, Dehpour AR (2009) Inhibition by lithium of the nitrergic relaxation of rat anococcygeus muscle. Nitric Oxide 20(1):31–38. doi:10.1016/j.niox.2008.08.007
14. Konradi C, Eaton M, MacDonald ML, Walsh J, Benes FM, Heckers S (2004) Molecular evidence for mitochondrial dysfunction in bipolar disorder. Arch Gen Psychiatry 61(3):300–308
15. Krämer DK, Bouzakri K, Holmqvist O, Al-Khalili L, Krook A (2005) Effect of serum replacement with plysate on cell growth and metabolismin primary cultures of human skeletal muscle. Cytotechnology 48(1–3):89–95. doi:10.1007/s10616-005-4074-7
16. Li N, Ragheb K, Lawler G, Sturgis J, Rajwa B, Melendez JA, Robinson JP (2003) Mitochondrial complex I inhibitor rotenone induces apoptosis through enhancing mitochondrial reactive oxygen species production. J Biol Chem 278(10):8516–8525. doi:10.1074/jbc.M210432200
17. Li Q, Li H, Roughton K, Wang X, Kroemer G, Blomgren K, Zhu C (2010) Lithium reduces apoptosis and autophagy after neonatal hypoxia-ischemia. Cell Death Dis 1:e56. doi:10.1038/cddis.2010.33
18. Maurer IC, Schippel P, Volz HP (2009) Lithium-induced enhancement of mitochondrial oxidative phosphorylation in human brain tissue. Bipolar Disord 11(5):515–522. doi:10.1111/j.1399-5618.2009.00729.x
19. Naoi M, Maruyama W, Shamoto-Nagai M, Yi H, Akao Y, Tanaka M (2005) Oxidative stress in mitochondria: decision to survival and death of neurons in neurodegenerative disorders. Mol Neurobiol 31(1–3):81–93
20. Ray PD, Huang BW, Tsuji Y (2012) Reactive oxygen species (ROS) homeostasis and redox regulation in cellular signaling. Cell Signal 24(5):981–990. doi:10.1016/j.cellsig.2012.01.008
21. Scola G, Kim HK, Young LT, Andreazza AC (2013) A fresh look at complex I in microarray data: clues to understanding disease-specific mitochondrial alterations in bipolar disorder. Biol Psychiatry 73(2):e4–e5. doi:10.1016/j.biopsych.2012.06.028
22. Shao L, Cui J, Young LT, Wang JF (2008) The effect of mood stabilizer lithium on expression and activity of glutathione s-transferase isoenzymes. Neuroscience 151(2):518–524
23. Takeda K, Akagi S, Takahashi S, Onishi A, Hanada H, Pinkert CA (2002) Mitochondrial activity in response to serum starvation in bovine (Bos taurus) cell culture. Cloning Stem Cells 4(3):223–229. doi:10.1089/15362300260339502
24. van der Valk J, Brunner D, De Smet K, Fex Svenningsen A, Honegger P, Knudsen LE, Lindl T, Noraberg J, Price A, Scarino ML, Gstraunthaler G (2010) Optimization of chemically defined cell culture media–replacing fetal bovine serum in mammalian in vitro methods. Toxicol In Vitro 24(4):1053–1063. doi:10.1016/j.tiv.2010.03.016
25. Watabe M, Nakaki T (2004) Rotenone induces apoptosis via activation of bad in human dopaminergic SH-SY5Y cells. J Pharmacol Exp Ther 311(3):948–953. doi:10.1124/jpet.104.071381
26. Watabe M, Nakaki T (2007) Mitochondrial complex I inhibitor rotenone-elicited dopamine redistribution from vesicles to cytosol in human dopaminergic SH-SY5Y cells. J Pharmacol Exp Ther 323(2):499–507. doi:10.1124/jpet.107.127597
27. Wegener G, Bandpey Z, Heiberg IL, Volke V, Trabace L, Rosenberg R, Harvey BH (2004) Combined chronic treatment with citalopram and lithium does not modify the regional neurochemistry of nitric oxide in rat brain. J Physiol Pharmacol 55(3):575–586
28. Zheng X, Baker H, Hancock WS, Fawaz F, McCaman M, Pungor E (2006) Proteomic analysis for the assessment of different lots of fetal bovine serum as a raw material for cell culture. Part IV. Application of proteomics to the manufacture of biological drugs. Biotechnol Prog 22(5):1294–1300. doi:10.1021/bp060121o